We are live on
!
Find out more
BCI
Bain Capital Investors Portfolio holdings
AUM
$3.27B
1-Year Est. Return
3.23%
This Fund
S&P 500
This Quarter
Est. Return
+11.39%
1 Year Est. Return
+3.23%
3 Year Est. Return
+87.05%
5 Year Est. Return
+97.69%
10 Year Est. Return
+813.76%
AUM
$3.88B
AUM Growth
+$387M
(+11%)
Cap. Flow
-$33.3M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KMTS
Kestra Medical Technologies
KMTS
|
+$621M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutanix
NTNX
|
+$408M |
| 2 |
WAY
Waystar Holding Corp
WAY
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 80.19% |
| 2 | Technology | 19.7% |
| 3 | Communication Services | 0.11% |
Similar funds
AIP
PCM
SM
EWA
SYBT
HP
KIM
YCM
Bain Capital Investors's Q1 2025 Portfolio in Review
As of Q1 2025, Bain Capital Investors held 6 positions worth $3.88B, up 11% from $3.5B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Bain Capital Investors's Q1 2025 filing shows 1 new and 2 reduced positions. Its largest new stake was Kestra Medical Technologies: 27,019,225 shares worth $673M. The largest sale was Nutanix, an estimated $408M.
By sector, the portfolio is most concentrated in Healthcare at 80% of assets, up from 70% a quarter earlier, followed by Technology and Communication Services.
- Bain Capital Investors's largest Q1 2025 buy was Kestra Medical Technologies: 27,019,225 shares worth $673M.
- Bain Capital Investors's biggest Q1 2025 reduction was Nutanix, cutting an estimated $408M.
- Bain Capital Investors's ten largest holdings make up 100% of its $3.88B portfolio in Q1 2025.
- Bain Capital Investors opened 1 new position and closed 0 in Q1 2025.
- Bain Capital Investors's portfolio value rose 11% quarter-over-quarter to $3.88B.
Based on Bain Capital Investors's 13F filing for Q1 2025, filed 15 May 2025.